Please select the option that best describes you:
Topics:
Rheumatology • Rheumatoid Arthritis
Would you switch to a TNF-I if patient developed squamous cell skin cancer on Orencia after failure of MTX for seropositive RA?
patient had no prior TNF-I exposure and was not on MTX while receiving Orencia